Sorafenib Dose Escalation is Not Uniformly Associated with Blood Pressure Elevations in Normotensive Patients with Advanced Malignancies

Hypertension with vascular endothelial growth factor (VEGF) receptor inhibitors is associated with superior treatment outcomes for advanced cancer patients. To determine whether increased doses of sorafenib cause incremental increases in blood pressure (BP) we measured 12-hour ambulatory BP in 41 no...

Descripción completa

Detalles Bibliográficos
Autores principales: Karovic, Sanja, Wen, Yujia, Karrison, Theodore G., Bakris, George L., Levine, Matthew R., House, Larry K., Wu, Kehua, Thomeas, Vasiliki, Rudek, Michelle A., Wright, John J., Cohen, Ezra E.W., Fleming, Gini F., Ratain, Mark J., Maitland, Michael L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165641/
https://www.ncbi.nlm.nih.gov/pubmed/24637941
http://dx.doi.org/10.1038/clpt.2014.63

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165641/
https://www.ncbi.nlm.nih.gov/pubmed/24637941
http://dx.doi.org/10.1038/clpt.2014.63

Ejemplares similares